Most advice on profit booking comes as a number. Book at 20%. Book at 25%. Sell half when it doubles and let the rest ride.
A percentage says nothing about the business. A stock up 25% in six months may be a thesis that has barely started, and a stock up 25% in three years may be one that has finished. The rule treats them the same, so it ends up selling the first kind, which is the stock you most wanted to own.
What is profit booking, and when is it the right call?
Profit booking, also called booking profits or profit-taking, is selling shares that are worth more than you paid, so the gain becomes cash. You can book a whole position or part of it. Any sale at a gain counts, which is why the term carries so little information by itself. The reason for the sale is what matters.
For a stock you bought on a thesis, two good reasons to book profit come from the stock itself.
The thesis has played out. You bought on a specific claim about the business, say that margins would expand from 11% to 15%. When the claim has come true and the market has priced it in, the reason you owned the stock is spent. Unless you can write a new thesis with the same care as the first, the position is running on memory and momentum.
The price has run past what the thesis can carry. Sometimes the thesis is intact and still in progress, but the price already assumes it will finish early, finish bigger and keep going after. If even the optimistic version of your thesis doesn't justify the valuation, the risk has moved to your side of the table. This is the valuation-extreme exit condition, and most investors never write it down, because it means committing in advance to sell a business they like.
A third reason comes from the portfolio: a clearly better use of the money. That sale is a switch, judged against the role you gave each position, and when to sell a stock covers it.
Everything else, from a round-number target to the fear of giving a gain back, is the reflex. It feels like prudence. Over a few years it is how winners get sold early.
Why "book profits at 20%" sells your winners early
The 20 to 25% rule is the most common answer online, and it fails for a structural reason. Every stock that ends up multiplying your money crosses 20% on the way, usually early. A rule that sells at a fixed gain sells those stocks while they are still small wins, and keeps the ones that never got going.
Two biases push the same way. Anchoring makes your buy price the reference point, so a gain feels like something the market lent you and can take back. Loss aversion makes giving back a paper gain hurt more than a further gain pleases. Together they make selling feel safe when, for a compounding business, it is the riskier choice.
The third problem comes after the sale. Few investors buy back a stock they sold at ₹500 once it trades at ₹700. It now looks expensive against the price they sold at, which is the same anchor working in reverse. So the booked winner usually leaves the portfolio for good, and the cash goes into an idea you rated lower when you had the choice.
Booking also triggers tax. At FY27 rates, gains on listed shares held for more than a year are taxed at 12.5% above ₹1.25 lakh in a financial year, and gains on shares held for a year or less at 20%. Holding defers that bill and leaves the untaxed amount compounding. Tax alone shouldn't decide a sale, but it belongs on the scale, and a percentage rule leaves it off.
Holding is a decision you remake every quarter
Underneath the percentage rule sits a belief that buying and selling require thought while holding requires nothing. You researched before buying. You'll research before selling. In between, holding is waiting, and waiting feels safe.
Holding is not the absence of a decision. It is a decision, made every quarter, whether you make it explicitly or not.
The default version: you buy a stock on a thesis. Results come in every quarter. You glance at the headline number, form a vague impression ("fine", "not great") and move on. You never check whether the specific KPI that justified the buy is still tracking, or whether the exit condition you had in mind has been crossed. Three quarters go by this way. The business may be compounding or quietly deteriorating, and you couldn't say which.
Patience is an active judgment: you've checked the thesis and decided the noise isn't a signal. Passive holding skips the check. The position is held because you haven't decided otherwise, and a position held that way is the easiest one to sell on a round number.
The active version takes ten to fifteen minutes per stock when results land. Pull up the thesis, check the KPI that matters most and compare it with the condition you wrote. Then state the decision in a sentence. The thesis is intact, so I hold. It is weakening, so I note what to watch next quarter. It has played out or broken, so I sell.
That quarterly verdict is what turns profit booking from a reflex into a decision. When a stock is up 60% and the gain is flashing on Kite, the call rests on a thesis you've already reviewed four times, and the answer is usually plain.
Stockport is built around this review. It reads the claims in your notes on each stock and asks what would break or fulfil each one. Each quarter it lines the results up against those claims and keeps score, and you log your verdict (hold, add, trim or exit) and why.
Partial profit booking: tranching out the way you tranched in
Partial profit booking means selling part of a position and keeping the rest. It has one good use and one bad one.
The good use is the valuation extreme. When the price has run past what the thesis can carry but the business is still executing, selling everything bets that you know exactly how far the overvaluation will go. Selling in tranches doesn't need that precision. Write the steps before you buy: a third at the valuation you named, another third if it runs a set distance further, and the rest held for as long as a thesis holds. You built the position in tranches as conviction grew. You can reduce it the same way as the price runs ahead of the business.
The bad use is nerves. Selling half "to be safe" when nothing in the thesis or the valuation has changed is the same reflex at half the size. It feels balanced because you can't be fully wrong. You can't be fully right either, and the half you sold came out of your best idea.
The test is the same as for a full sale. Can you point to the written condition this sale meets? If you can, tranching is a good way to act on it. If you can't, the sale is the reflex.
Ashvik Fasteners: three moments to book or hold (made up)
Ashvik Fasteners is a made-up company. Its numbers are invented to show the pattern.
Ashvik makes fasteners for auto makers. In January 2023, at ₹420 and 25 times trailing earnings, the thesis reads: exports rise from 18% to 30% of revenue and EBITDA margin from 11% to 15% by FY27, as approvals from two US auto makers turn into orders. The valuation condition, written the same day: above 45 times trailing earnings, sell a third; above 55 times, another third; hold the rest while a thesis holds.
Moment one: ₹525 in June 2023, up 25%. Exports are at 19%. The first US order has been announced, and the market has priced the news. Nothing in the thesis has played out yet. The percentage rule says book. The thesis says it has barely started. The decision is hold, with the reason written down.
Moment two: ₹780 after the Q2 FY25 results, up 86%. Exports are 25% of revenue and the margin is 13.5%. The stock trades at 30 times trailing earnings. The thesis is on track, and the price sits well inside what it can carry if it completes. This is the quarter the gain feels most fragile, because it is large and you've lived with it long enough to fear losing it. The verdict is hold, stated in the review: thesis intact, valuation inside the line.
Moment three: ₹1,500 after the Q2 FY26 results, up 257%. Exports have been above 30% of revenue and the margin above 15% for two quarters running, a year and a half ahead of schedule. The stock trades at 50 times trailing earnings, past the 45 you wrote down, and the original thesis has nothing left to grow into. This is profit booking for the right reasons: the thesis has played out and the price has outrun it. Sell the first third. If you can write a new thesis (a second export market, a new product line) with the same care as the first, hold the rest on it, still under the valuation steps. If you can't, the reason to own the stock is spent, so sell the rest as well.
The investor who booked at 25% sold at ₹525 and kept ₹105 a share. The investor on the thesis held through two quarters that tempted a sale, and booked at ₹1,500 for a reason written down nearly three years earlier.
What booking too early costs: the behaviour gap
Each booked winner shows a profit on its contract note, so the cost is easy to miss. Part of it shows up in the gap between two returns.
TWRR, the time-weighted return, measures how the stocks you held performed, period by period, whatever amount of money sat in them. XIRR measures what your money made, weighted by when you bought, when you sold and how much. The difference is the behaviour gap: the part of your return that comes from when and how much you put in and took out.
Booking a winner early takes money out of the portfolio. If what you still hold does better after the sale than it did before, TWRR counts that stronger stretch at full weight, while XIRR counts it only on the money you left in. XIRR falls behind, and the calculator reports the shortfall as a behaviour drag. Sell a whole position that goes on rising and part of the cost escapes both numbers, because neither follows a stock after you've left it.
An investor who makes the holding decision against the thesis each quarter makes fewer trades, and fewer of them on a reflex. Fewer self-inflicted decisions bring XIRR closer to TWRR: the behaviour gap shrinks because less of what your holdings earned is lost to timing.
You can measure your own gap from a broker tradebook with the free XIRR vs TWRR calculator.
When doesn't this apply?
If a thesis breaks clearly (a single event, an unambiguous KPI failure), sell without waiting for the quarterly review. That sale is an exit on a broken thesis even if the stock is up, and when to sell a stock covers it.
If you need the money, sell. A thesis decides what to own. It doesn't outrank a home loan or a family need.
If you trade, the rules are different. A trader's edge is in price behaviour, and booking at a target is part of a complete system. This article is for investors who buy a business on a thesis and hold it for years.
The quarterly check, run once per stock
| Check | What it looks like in practice |
|---|---|
| Pull up the original thesis | One sentence: the business condition that has to stay true |
| Check the KPI that matters most | From the quarterly result, not the stock price |
| Has the thesis played out? | Every claim met and priced in? Then book, or write the next thesis |
| Is the price past what the thesis can carry? | Compare with the valuation you wrote before buying |
| Compare against your pre-written exit condition | Has the threshold been crossed? Yes or No |
| State the decision explicitly | "I hold because the thesis is intact" or "I book because it has played out" |
If the thesis is intact and the price is inside your line: hold, and say so. The decision is on record.
If the price has passed your valuation line: sell in the tranches you wrote.
If the thesis has played out: book, or write the next thesis before you keep holding.
If you have no written exit condition or valuation line: write both before next quarter's results. Without them, every gain becomes a fresh decision made under pressure.